Supporting 25% of novel drug approvals* across FDA and EMA Signant Health's technology and services have supported a quarter of all regulatory authorizations for new active substances in their first indications across major global markets
A Massachusetts man has filed a product liability lawsuit against Novo Nordisk, alleging that Wegovy caused him to develop non-arteritic anterior ischemic optic neuropathy (NAION), resulting in permanent blindness in his left eye
Doctors may provide free Mounjaro samples to new patients trying the medication, typically consisting of four 2.5-milligram single-use pens for one month, though availability is not guaranteed
While increased adiposity (i.e., overweight and obesity) is the usual driver of IR, other factors may play a role in the development of IR in T1D
The same clinical review noted a similar prevalence of insomnia among those taking a placebo, which implies that the medicine itself does not directly cause or worsen chronic sleep issues
